SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Review of the Use of the Glutamate Antagonist Riluzole in Psychiatric Disorders and a Description of Recent Use in Childhood Obsessive-Compulsive Disorder
4 references·2 citing·26 second hop
Review of the Use of the Glutamate Antagonist Riluzole in Psychiatric Disorders and a Description of Recent Use in Childhood Obsessive-Compulsive Disorder (2010)Review of the Use of the Glutamate Antago…An Open-Label Trial of Riluzole, a Glutamate Antagonist, in Children with Treatment-Resistant Obsessive-Compulsive Disorder (2007)An Open-Label Trial of Riluzo…Riluzole Augmentation in Treatment-Resistant Obsessive–Compulsive Disorder: An Open-Label Trial (2005)Riluzole Augmentation in Trea…Open-Label Trial of Riluzole in Generalized Anxiety Disorder (2005)Open-Label Trial of Riluzole …Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder (2003)Beneficial effects of the ant…Glutamate-Modulating Drugs as a Potential Therapeutic Strategy in Obsessive-Compulsive Disorder (2017)Glutamate-Modulating Drugs as…A review of obsessive-compulsive disorder in children and adolescents (2011)A review of obsessive-compuls…Obsessive Compulsive Disorder in Adolescence: An Epidemiological Study (1988)New developments in childhood affective and anxiety disorders (1994)Cognitive-Behavior Therapy, Sertraline, and Their Combination for Children and Adolescents With Obsessive-Compulsive Disorder (2004)Meta-Analysis of the Symptom Structure of Obsessive-Compulsive Disorder (2008)Obsessive-compulsive symptoms and obsessive-compulsive disorder in adolescents: a population-based study (2013)Sex differences in the genetic architecture of obsessive–compulsive disorder (2018)Multicenter Collaborative Panic Disorder Severity Scale (1997)A Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Adjunctive Paroxetine in Panic Disorder Patients Unsuccessfully Treated With Cognitive-Behavioral Therapy Alone (2002)Pregabalin in Generalized Anxiety Disorder: A Placebo-Controlled Trial (2003)Novel treatment approaches for refractory anxiety disorders (2007)Riluzole Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder (2015)Decrease in Caudate Glutamatergic Concentrations in Pediatric Obsessive-Compulsive Disorder Patients Taking Paroxetine (2000)N-Acetyl Cysteine, a Glutamate-Modulating Agent, in the Treatment of Pathological Gambling: A Pilot Study (2007)The role of glutamate signaling in the pathogenesis and treatment of obsessive–compulsive disorder (2011)Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders (2019)FUNCTIONAL NEUROIMAGING AND THE NEUROANATOMY OF OBSESSIVE-COMPULSIVE DISORDER (2000)Glutamatergic Dysfunction in OCD (2005)Glutamate Transporter Gene SLC1A1 Associated With Obsessive-compulsive Disorder (2006)Anti-Brain Autoantibodies and Altered Excitatory Neurotransmitters in Obsessive–Compulsive Disorder (2009)Animal models of obsessive-compulsive disorder: Exploring pharmacology and neural substrates (2011)Effects of Ketamine in Treatment-Refractory Obsessive-Compulsive Disorder (2012)Randomized, Placebo-Controlled Trial of Exposure and Ritual Prevention, Clomipramine, and Their Combination in the Treatment of Obsessive-Compulsive Disorder (2004)The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication (2008)Voxel-wise meta-analysis of grey matter changes in obsessive–compulsive disorder (2009)Pharmacological Management of Treatment-Resistant Obsessive-Compulsive Disorder (2011)Treatment-resistant OCD: Pharmacotherapies in adults (2022)
this work references cited by second hop

References

  • 2005Riluzole Augmentation in Treatment-Resistant Obsessive–Compulsive Disorder: An Open-Label Trial314 cited
  • 2007An Open-Label Trial of Riluzole, a Glutamate Antagonist, in Children with Treatment-Resistant Obsessive-Compulsive Disorder197 cited
  • 2005Open-Label Trial of Riluzole in Generalized Anxiety Disorder134 cited
  • 2003Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder118 cited

Cited by

  • 2017Glutamate-Modulating Drugs as a Potential Therapeutic Strategy in Obsessive-Compulsive Disorder83 cited
  • 2011A review of obsessive-compulsive disorder in children and adolescents78 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work